LatchBio is a biotech research company that provides code-free platform for the biocomputing revolution.
Sign up today and learn more about LatchBio Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About LatchBio Stock
LatchBio develops a data infrastructure intended to build and disseminate the open-source infrastructure of the biocomputing revolution. Founded in 2021 by Alfredo Andere, Kyle Giffin, and Kenny Workman, the company creates open-source machine learning and cloud infrastructure for the next generation of therapeutic discovery, thereby enabling biotech companies to find therapies faster and save on engineering.
Co-Founder and CEO
Co-founder and CTO
Co-founder, Chief Operating Officer